SCHEMBL7074768

SCHEMBL7074768

O=Cc1c[nH]c2cc(Cl)cc(Cl)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.46
CYP2A6 P11509 3/20 0.46
ERN1 O75460 2/20 0.44
IMPDH2 P12268 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29957147 0.82 CYP2A6 (0.44) GPR17CYP2A6ERN1IMPDH2TDP1
SCHEMBL29953083 0.82 CYP2A6 (0.44) CYP2A6ERN1IMPDH2CYP1A2CYP2C19
SCHEMBL29955776 0.82 ERN1 (0.46) GPR17CYP2A6ERN1IMPDH2CYP1A2
SCHEMBL29957909 0.82 CYP2A6 (0.40) GPR17CYP2A6ERN1IMPDH2TDP1
SCHEMBL17417808 0.82 CYP2A6 (0.44) CYP2A6ERN1IMPDH2CYP1A2CYP2C19
SCHEMBL29953280 0.78 ERN1 (0.51) CYP2A6ERN1IMPDH2TDP1CYP1A2
SCHEMBL29954522 0.78 ALDH1A1 (0.55) CYP2A6ERN1IMPDH2CYP1A2CYP2C19
SCHEMBL17417767 0.78 ALDH1A1 (0.55) CYP2A6ERN1IMPDH2CYP1A2CYP2C19
SCHEMBL1337252 0.78 CYP2A6 (0.64) CYP2A6IMPDH2TDP1ALDH1A1MEN1
SCHEMBL29951940 0.78 CYP2A6 (0.64) CYP2A6IMPDH2TDP1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144421-B1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT ENERGIE ATOMIQUE (FR) 2003-10-08 EP claimed
US-6630501-B1 Treatment of cancer due to overexpression of enzymes of this family COMMISSARIAT A L'ENERGIE ATOMIQUE 2003-10-07 US claimed
JP-2003517450-A 2003-05-27 JP claimed
EP-1144421-A1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2001-10-17 EP claimed
WO-2000043404-A1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2000-07-27 WO claimed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-1144421-B1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT ENERGIE ATOMIQUE (FR) 2003-10-08 EP disclosed
US-6630501-B1 Treatment of cancer due to overexpression of enzymes of this family COMMISSARIAT A L'ENERGIE ATOMIQUE 2003-10-07 US disclosed
EP-1144421-A1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2001-10-17 EP disclosed
WO-2000043404-A1 PHOSPHINIC PSEUDOPEPTIDES INHIBITORS OF MATRIX METALLOPROTEASES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2000-07-27 WO disclosed